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xtracapillary  glomerulonephritis  and leprosy:
n uncommon  association
pra
ination was not possible.lomerulonefritis  extracapilar  y  le
ear Editor,
eprosy is a chronic disease caused by the intracellular bacil-
us Mycobacterium leprae,  which primarily affects the skin and
eripheral nerves.1 The clinical picture is variable; there are
aucibacillary forms with few lesions (tuberculoid leprosy),
nd multibacillary forms with numerous lesions (leproma-
ous leprosy), which occurs in patients with impaired cellular
mmunity.2 The presence of extracapillary glomerulonephritis
ith leprosy is rare, and here we describe the case of a patient
ith both diseases.
This was a 79-year-old man  diagnosed of leprosy at age 32,
ith both neurological and cutaneous involvement. He was
dmitted in March 2011 with oedema, haematuria, and wors-
ning of renal function. On examination, he was noted to have
eonine facies, loss of eyebrows, and a saddle nose. His skin
as rough with xerostomia and thickening, and there were
rythematous macules on the limbs. BP was 168/104. Venous
ressure was elevated, and there were bibasal crepitations and
eripheral oedema. There was reduced sensibility to touching
nd pain in the limbs.
Blood test revealed a haemoglobin of 11.9 g/dL, leukocytes
660/mm3, platelets 173,000/mm3, creatinine 2.31 mg/dL, and
rea 93 mg/dL. Transaminases, LDH, CK, cholesterol, triglyce-
ides, HDL, and LDL, were normal. Urinary sediment had >100
ed blood cells per ﬁeld (90% dysmorphic), with a 24 h protein-
ria of 1.3 g. Serology was negative for HIV, hepatitis B and C
irus. ANA, ANCA, and anti-glomerular basement membrane
ntibodies were negative, and C3 and C4 were normal. Chest
-ray showed vascular redistribution and a left-sided pleu-
al effusion. Abdominal ultrasound showed kidneys of normal
ize with increased cortical echogenicity with no other abnor-
alities.
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Percutaneous renal biopsy was performed and showed
a proliferative endocapillary and extracapillary glomeru-
lonephritis affecting most glomeruli (Fig. 1). Immunoﬂuores-
cence was negative, there were no amyloid deposits, and no
acid-alcohol fast bacilli using Fite technique. Treatment was
started with 3 boluses of 6-methyl-prednisolone and there-
after oral prednisone (60 mg  daily) and cyclophosphamide
(100 mg  daily). Renal function progressively deteriorated, and
treatment with haemodialysis was started via a tunnelled
right jugular catheter.
In May 2011, pancytopenia was observed, so cyclophos-
phamide was stopped and treatment with sodium mycophe-
nolate was started (360 mg  every 12 h). In June 2011, he was
readmitted with bilobar pneumonia, so sodium mycophe-
nolate treatment was stopped deﬁnitively, and prednisone
continued, at a reducing dose.
In August 2011, due to the appearance of cutaneous lesions
in the lower limbs, biopsy was performed, which showed areas
of dermal necrosis associated with macrophages with focal
images of leukocytoclastic vasculitis of small vessels, com-
patible with a diagnosis of type II lepra reaction (borderline
lepromatous) (Fig. 2). Treatment was started with dapsone
(100 mg  daily), clofazimine (50 mg  daily), and rifampicin
(300 mg  per month). He was readmitted in October 2011 for
severe anaemia with a haemoglobin of 5.7 g/dL, and diagnosed
with haemolytic anaemia secondary to dapsone, which was
stopped. The patient continued on haemodialysis treatment,
and died following a haemopericardium in relation to the
change of jugular catheter in July 2012. Post-mortem exam-odríguez-Palomaresa JR, Pernab C. Glomerulonefritis extracapilar
Conclusions: leprosy, particularly in the lepromatous form,
can cause secondary renal amyloidosis, especially in patients
who have recurrent episodes of associated erythema nodosum
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Fig. 1 – Renal biopsy. Methenamine-silver staining.
Glomeruli are seen with increased cellularity, at an
endocapillary level and with formation of extracapillary
crescents.
Fig. 2 – Skin biopsy. Extensive areas of necrosis can be seen
in the dermis.
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S.L.U. on behalf of Sociedad Espan˜ola de Nefrologı´a. This isor chronic skin ulcers; tubulointerstitial nephropathies, both
acute and chronic can also occur.3–5 Finally, several types of
immune complex glomerulonephritis have been described,
such as proliferative endocapillary, proliferative mesangial,
membranoproliferative, and focal glomerulosclerosis.3–5
Extracapillary forms have been described in exceptional
cases.6–10 Typically, patients present with acute renal failure.
In some cases, the presence of bacilli has been demon-
strated in the renal parenchyma at a glomerular level and in
the interstitium.7 The mechanisms connecting extracapillary
glomerulonephritis with negative immunoﬂuorescence and
leprosy are not well-known, but it is possible that the immune
abnormalities produced in leprosy could favour the generation
of glomerulonephritis.
In these patients, the appropriate treatment must
be considered. In our case, treatment was started with;3 6(3):313–314
cyclophosphamide, and subsequently, mycophenolate
sodium with steroids. It is highly possible that this treatment
contributed was key in the reactivation of leprosy as was con-
ﬁrmed on cutaneous biopsy, therefore prophylactic treatment
with dapsone or clofazimine should be considered in such
cases.
Leprosy treatment in patients on dialysis is difﬁcult
because there is little experience with the drugs used, and the
dose must be adjusted. The risk of side effects increases, and
in fact, our patient had severe haemolytic anaemia, possibly
secondary to dapsone treatment.
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